Early diagnosis leads to earlier treatment. With earlier treatment of rheumatoid arthritis (RA), there is a better chance for less radiographic damage, less disability and thus lower overall costs of ...

Rheumatoid arthritis-associated interstitial lung disease (ILD) presents a paradox: it is common and a major cause of morbidity and mortality, yet continues to lack a consistent, evidence-based ...

Advances in RA treatment require improved understanding of patient-specific therapy appropriateness, focusing on disease pathogenesis and heterogeneity. Current RA treatment algorithms lack biomarkers ...

1 in 100 people in Britain today live with rheumatoid arthritis (RA). Unlike osteoarthritis (OA), RA is caused not by wear and tear but by the body's immune system attacking its own joints. RA can ...

A promising new study suggests rheumatoid arthritis may not be as inevitable as once thought for people at high risk.

Cedars-Sinai’s center provides personalized, multidisciplinary care for RA and related conditions, improving patient outcomes and quality of life. Dr. Jon Giles' research explores autoimmune disease ...